Robust protection
COVID-19 vaccine candidate at Beth Israel prevents severe clinical disease in animals. Read Article
Entries by Morgana Souza
The Importance of Diversifying Covid Clinical Trials
In this edition of “Bloomberg Equality,” Dr. Kathryn Stephenson of Harvard Medical School talks with Bloomberg’s Scarlet Fu about the history of Black and Latino communities feeling left out of […]
Scientists See Downsides to Top COVID-19 Vaccines From Russia, China
“Demonstrating safety and efficacy of a vaccine is very important,” said Dr. Dan Barouch, a Harvard vaccine researcher who helped design J&J’s COVID-19 vaccine. Read Article
Scientists see downsides to top COVID-19 vaccines from Russia, China
Many experts expressed skepticism about the Russian vaccine after the government declared its intention to give it to high-risk groups in October without data from large pivotal trials. Read Article
Four scenarios on how we might develop immunity to Covid-19
As the world wearies of trying to suppress the SARS-CoV-2 virus, many of us are wondering what the future will look like as we try to learn to live with […]
1st documented COVID-19 reinfection isn’t surprising, but may offer important clues about virus, experts say
“It’s an interesting and important case report. It answers the question [of] whether it’s possible to get re-infected: The answer is yes.” – Dan Barouch Read Article
Will need ‘multiple’ types of coronavirus vaccines to succeed against pandemic: Top Harvard scientist
Researchers will need to develop multiple types of coronavirus vaccines to address the immense scale of the outbreak, Harvard University vaccine researcher Dr. Dan Barouch told Yahoo Finance in a […]
Coronavirus vaccine ‘possible’ by winter: Top Harvard scientist
A coronavirus vaccine is “possible” by the end of 2020, but will not become widely available until 2021, Harvard University vaccine researcher Dr. Dan Barouch told Yahoo Finance in a […]
‘Cautious optimism’ – J&J vaccine trials underway
With more than 20 COVID-19 vaccines in clinical trials, the collaboration between Johnson & Johnson and Beth Israel Deaconess in Boston is getting $1 billion in U.S. funding. Lead researcher […]
Inside 1 lab’s race to create a COVID19 vaccine
6 companies aside from Johnson & Johnson are in phase 3 of human trials, but the scientists working round the clock at the company’s lab in Boston could see a […]
